Trupanion, Inc. (NASDAQ:TRUP – Get Rating) – Equities research analysts at Jefferies Financial Group issued their Q3 2022 earnings per share estimates for shares of Trupanion in a note issued to investors on Wednesday, September 21st. Jefferies Financial Group analyst C. Grady expects that the financial services provider will earn ($0.31) per share for the quarter. Jefferies Financial Group currently has a "Buy" rating and a $77.00 target price on the stock. The consensus estimate for Trupanion's current full-year earnings is ($1.03) per share. Jefferies Financial Group also issued estimates for Trupanion's Q4 2022 earnings at ($0.29) EPS, FY2022 earnings at ($1.15) EPS, Q1 2023 earnings at ($0.26) EPS, Q2 2023 earnings at ($0.27) EPS, Q3 2023 earnings at ($0.25) EPS, Q4 2023 earnings at ($0.24) EPS, FY2023 earnings at ($1.01) EPS and FY2024 earnings at ($0.93) EPS.

Trupanion (NASDAQ:TRUP – Get Rating) last released its quarterly earnings results on Wednesday, August 3rd. The financial services provider reported ($0.33) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.10). The firm had revenue of $219.41 million during the quarter, compared to analyst estimates of $216.63 million. Trupanion had a negative return on equity of 10.62% and a negative net margin of 4.53%.

Trupanion Stock Performance

TRUP opened at $59.29 on Friday. The stock has a market cap of $2.42 billion, a P/E ratio of -66.62 and a beta of 1.95. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.78 and a quick ratio of 1.78. The stock's 50 day simple moving average is $68.33 and its 200 day simple moving average is $70.19. Trupanion has a 1-year low of $50.81 and a 1-year high of $158.25.

Insider Buying and Selling at Trupanion

In other Trupanion news, Director Michael Doak sold 700 shares of the stock in a transaction on Tuesday, July 5th. The stock was sold at an average price of $60.00, for a total transaction of $42,000.00. Following the sale, the director now owns 1,007 shares in the company, valued at approximately $60,420. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, Director Michael Doak sold 700 shares of the firm's stock in a transaction on Tuesday, July 5th. The stock was sold at an average price of $60.00, for a total transaction of $42,000.00. Following the sale, the director now owns 1,007 shares in the company, valued at $60,420. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gavin Friedman sold 1,600 shares of the firm's stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $80.00, for a total value of $128,000.00. Following the sale, the executive vice president now owns 6,968 shares in the company, valued at approximately $557,440. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 28,207 shares of company stock worth $1,934,952. 5.86% of the stock is owned by insiders.

Institutional Investors Weigh In On Trupanion

Hedge funds have recently made changes to their positions in the business. Greenhaven Road Investment Management L.P. acquired a new stake in shares of Trupanion during the second quarter worth $32,000. Prospera Financial Services Inc purchased a new position in shares of Trupanion in the 1st quarter worth $49,000. Tcwp LLC purchased a new position in shares of Trupanion in the 1st quarter worth $54,000. Harbor Investment Advisory LLC raised its position in shares of Trupanion by 33.5% in the 1st quarter. Harbor Investment Advisory LLC now owns 714 shares of the financial services provider's stock worth $64,000 after buying an additional 179 shares during the period. Finally, Captrust Financial Advisors raised its position in shares of Trupanion by 162.6% in the 1st quarter. Captrust Financial Advisors now owns 893 shares of the financial services provider's stock worth $80,000 after buying an additional 553 shares during the period. Institutional investors and hedge funds own 97.85% of the company's stock.

Trupanion Company Profile

(Get Rating)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

• Get a free copy of the StockNews.com research report on Trupanion (TRUP)
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• 2 Semiconductor Stocks To Watch For Reversals
• Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
• Is Costco's Post-Earnings Price Weakness A Good Time To Buy?

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.